Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Prospects of Molecular Biotechnology in Diagnostics: Step Towards Precision Medicine.

Literature DB >> 28428685

Prospects of Molecular Biotechnology in Diagnostics: Step Towards Precision Medicine.

Praveen Sharma¹, Shailendra Dwivedi¹.

Abstract

Year: 2017 PMID： 28428685 PMCID： PMC5382087 DOI： 10.1007/s12291-017-0650-9

Source DB: PubMed Journal: Indian J Clin Biochem ISSN： 0970-1915

× No keyword cloud information.

6 in total

1. Functional genetic variability at promoters of pro-(IL-18) and anti-(IL-10) inflammatory affects their mRNA expression and survival in prostate carcinoma patients: Five year follow-up study.

Authors: Shailendra Dwivedi; Apul Goel; Anil Mandhani; Sanjay Khattri; Praveen Sharma; Sanjeev Misra; Kamlesh Kumar Pant
Journal: Prostate Date: 2015-08-17 Impact factor: 4.104

2. Non-invasive biomarker in prostate carcinoma: a novel approach.

Authors: Shailendra Dwivedi; Kamla Kant Shukla; Geetanjali Gupta; Praveen Sharma
Journal: Indian J Clin Biochem Date: 2013-04

3. Advancing the education in molecular diagnostics: the IFCC-Initiative "Clinical Molecular Biology Curriculum" (C-CMBC); a ten-year experience.

Authors: Evi Lianidou; Parviz Ahmad-Nejad; Andrea Ferreira-Gonzalez; Kenji Izuhara; Laura Cremonesi; Maria-Eugenia Schroeder; Karin Richter; Maurizio Ferrari; Michael Neumaier
Journal: Clin Chim Acta Date: 2014-05-09 Impact factor: 3.786

4. Genetic variability at promoters of IL-18 (pro-) and IL-10 (anti-) inflammatory gene affects susceptibility and their circulating serum levels: An explorative study of prostate cancer patients in North Indian populations.

Authors: Shailendra Dwivedi; Apul Goel; Sanjay Khattri; Anil Mandhani; Praveen Sharma; Sanjeev Misra; Kamlesh Kumar Pant
Journal: Cytokine Date: 2015-04-16 Impact factor: 3.861

Review 5. Integration of molecular pathology, epidemiology and social science for global precision medicine.

Authors: Akihiro Nishi; Danny A Milner; Edward L Giovannucci; Reiko Nishihara; Andy S Tan; Ichiro Kawachi; Shuji Ogino
Journal: Expert Rev Mol Diagn Date: 2015-12-04 Impact factor: 5.225

6. Tobacco exposure by various modes may alter proinflammatory (IL-12) and anti-inflammatory (IL-10) levels and affects the survival of prostate carcinoma patients: an explorative study in North Indian population.

Authors: Shailendra Dwivedi; Apul Goel; Sanjay Khattri; Anil Mandhani; Praveen Sharma; Kamlesh Kumar Pant
Journal: Biomed Res Int Date: 2014-08-07 Impact factor: 3.411

6 in total

1. MicroRNAs and Diseases: Promising Biomarkers for Diagnosis and Therapeutics.

Authors: Shailendra Dwivedi; Purvi Purohit; Praveen Sharma
Journal: Indian J Clin Biochem Date: 2019-07-19

2. Methods for Isolation of High Quality and Quantity of miRNA and Single Cell Suspension for Flow-Cytometry from Breast Cancer Tissue: A Comparative Analysis.

Authors: Shailendra Dwivedi; Purvi Purohit; Radhieka Misra; Puneet Pareek; Jeewan Ram Vishnoi; Sanjeev Misra; Praveen Sharma
Journal: Indian J Clin Biochem Date: 2017-11-29

Prospects of Molecular Biotechnology in Diagnostics: Step Towards Precision Medicine.

1. Functional genetic variability at promoters of pro-(IL-18) and anti-(IL-10) inflammatory affects their mRNA expression and survival in prostate carcinoma patients: Five year follow-up study.

2. Non-invasive biomarker in prostate carcinoma: a novel approach.

3. Advancing the education in molecular diagnostics: the IFCC-Initiative "Clinical Molecular Biology Curriculum" (C-CMBC); a ten-year experience.

4. Genetic variability at promoters of IL-18 (pro-) and IL-10 (anti-) inflammatory gene affects susceptibility and their circulating serum levels: An explorative study of prostate cancer patients in North Indian populations.

Review 5. Integration of molecular pathology, epidemiology and social science for global precision medicine.

6. Tobacco exposure by various modes may alter proinflammatory (IL-12) and anti-inflammatory (IL-10) levels and affects the survival of prostate carcinoma patients: an explorative study in North Indian population.

1. MicroRNAs and Diseases: Promising Biomarkers for Diagnosis and Therapeutics.

2. Methods for Isolation of High Quality and Quantity of miRNA and Single Cell Suspension for Flow-Cytometry from Breast Cancer Tissue: A Comparative Analysis.

3. Nutrigenomics and Nutrigenetics: New Insight in Disease Prevention and Cure.

4. Tissue-Resident Memory Cells: New Marked Shield to Fight Cancers.

Review 5. Single Cell Omics of Breast Cancer: An Update on Characterization and Diagnosis.

6. Diseases and Molecular Diagnostics: A Step Closer to Precision Medicine.